×
About 9,738 results

ALLMedicine™ Organ Transplantation Center

Research & Reviews  3,572 results

Response to American College of Physician's statement on the ethics of transplant after...
https://doi.org/10.1111/ajt.16947
American Journal of Transplantation : Official Journal Of... Parent B, Caplan A et. al.

Jan 25th, 2022 - This paper responds to the position statement released by the American College of Physicians (ACP) entitled "Ethics, Determination of Death, and Organ Transplantation in Normothermic Regional Perfusion (NRP) with Controlled Donation after Circulat...

Endometrial Cancer After Pancreas-After-Kidney Transplantation: A Case Report and Revie...
https://doi.org/10.1016/j.transproceed.2021.12.021
Transplantation Proceedings; Kobayashi T, Miura K et. al.

Jan 25th, 2022 - As the number of long-term survivors after organ transplantation increases, malignancy has become a problem as a late complication. We herein report a case of endometrial cancer during the follow-up of pancreas transplantation after kidney transpl...

Temporal Trends in Brain-Death Organ Donation in Asia: Results From the Global Observat...
https://doi.org/10.1016/j.transproceed.2021.12.031
Transplantation Proceedings; Manla Y, AlSindi F et. al.

Jan 25th, 2022 - Organ shortage is the main limiting factor for further dissemination of organ transplantation therapies; implementation of brain-death (BD) criteria for organ donation purposes is essential for overcoming this limitation. Investigating and charact...

Cytomegalovirus and other herpesviruses after hematopoietic cell and solid organ transp...
https://doi.org/10.1016/j.trim.2022.101539
Transplant Immunology; Ivana T, Robert P et. al.

Jan 21st, 2022 - Herpesviruses can either cause primary infection or may get reactivated after both hematopoietic cell and solid organ transplantations. In general, viral infections increase post-transplant morbidity and mortality. Prophylactic, preemptive, or the...

see more →

Guidelines  13 results

Cancer immunotherapy in special challenging populations: recommendations of the Advisor...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009216
Journal for Immunotherapy of Cancer; Gonzalez-Cao M, Puertolas T et. al.

Mar 31st, 2021 - Cancer immunotherapy based on the use of antibodies targeting the so-called checkpoint inhibitors, such as programmed cell death-1 receptor, its ligand, or CTLA-4, has shown durable clinical benefit and survival improvement in melanoma and other t...

Management of metabolic alterations in adult kidney transplant recipients: A joint posi...
https://doi.org/10.1016/j.numecd.2020.05.004
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Conte C, Maggiore U et. al.

Jul 2nd, 2020 - Chronic metabolic alterations such as post-transplant diabetes mellitus (PTDM), dyslipidaemias and overweight/obesity significantly impact on kidney transplant (KT) outcomes. This joint position statement is based on the evidence on the management...

Guidelines for the Use of Transesophageal Echocardiography to Assist with Surgical Deci...
https://doi.org/10.1016/j.echo.2020.03.002
Journal of the American Society of Echocardiography : Off... Nicoara A, Skubas N et. al.

Jun 7th, 2020 - Intraoperative transesophageal echocardiography is a standard diagnostic and monitoring tool employed in the management of patients undergoing an entire spectrum of cardiac surgical procedures, ranging from "routine" surgical coronary revasculariz...

Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement ...
https://doi.org/10.1016/j.cjca.2019.12.025
The Canadian Journal of Cardiology; Chih S, McDonald M et. al.

Mar 9th, 2020 - Significant practice-changing developments have occurred in the care of heart transplantation candidates and recipients over the past decade. This Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement provides evid...

ASHP Guidelines on Pharmacy Services in Solid Organ Transplantation.
https://doi.org/10.1093/ajhp/zxz291
American Journal of Health-system Pharmacy : AJHP : Offic... Maldonado AQ, Hall RC et. al.

Dec 14th, 2019 - ASHP Guidelines on Pharmacy Services in Solid Organ Transplantation.|2019|Maldonado AQ,Hall RC,Pilch NA,Ensor CR,Anders S,|organization & administration,organization & administration,

see more →

Drugs  5 results see all →

Clinicaltrials.gov  102 results

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ Transplantation
https://clinicaltrials.gov/ct2/show/NCT05162456

Dec 17th, 2021 - The study includes patients of Antoni Jurasz University Hospital No.1 in Bydgoszcz after organ transplantation. To meet the inclusion criteria patients will have to be vaccinated with two doses of the BNT162b2 vaccine. The assessment of the anti-S...

Seroprevalence of Hepatitis E in People With an Organ Transplant
https://clinicaltrials.gov/ct2/show/NCT02190253

Dec 16th, 2021 - Hepatitis E virus infection commonly presents as an acute self-limiting hepatitis in the developing world. However there have been reports that chronic hepatitis E may develop in immunocompromised subjects such as renal and liver transplant recipi...

A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients
https://clinicaltrials.gov/ct2/show/NCT03950414

Dec 14th, 2021 - Viral infections, or their reactivation in the immunocompromised host, remain serious complications that adversely affect outcomes of transplantation. These infections may be refractory to pharmacologic treatment and result in increased morbidity ...

Extended Release Tacrolimus vs. Twice-Daily Tacrolimus
https://clinicaltrials.gov/ct2/show/NCT03289650

Dec 9th, 2021 - Kidney transplantation is the treatment of choice for most patients with end-stage renal disease. Lifelong immunosuppressive therapies are required to prevent organ rejection. However, long term exposure to immunosuppressive therapy after kidney t...

Mortality, Morbidity and Risk Factors of Liver Retransplantation
https://clinicaltrials.gov/ct2/show/NCT04789213

Dec 6th, 2021 - This study aims to compare the short and long term outcomes of living donor and deceased donor liver retransplantation. Bearing that in mind, the investigators will retrospectively analyze the files of patients whom underwent a liver retransplanta...

see more →

News  202 results

Should We Be Using COVID-Positive Donors for Organ Transplants?
https://www.medscape.com/viewarticle/962208

Nov 4th, 2021 - Arthur L. Caplan, PhD Most of us worry about catching COVID. We worry about getting sick, even very sick (even though most of us won't, even if infected). People waiting for an organ transplant are more likely to get severely sick if they catch th...

Study Exclusion Criteria Limits Real-World Benefit of Immunotherapy in Lung Cancer
https://www.onclive.com/view/study-exclusion-criteria-limits-realworld-benefit-of-immunotherapy-in-lung-cancer

Oct 6th, 2021 - Mohammad Jahanzeb, MD Immunotherapy has emerged as a frontline option for patients with metastatic non—small cell lung cancer, but it is important to note that patients eligible for these trials account for a small portion of all patients with lu...

Study Identifies Groups Still At Risk of Severe COVID Despite Vaccination
https://www.medscape.com/viewarticle/958956

Sep 18th, 2021 - Editor's note, 23 September 2021: The title of this article was amended for clarity. Researchers have identified groups of people most at risk of dying or experiencing severe disease from COVID-19 after receiving one or two doses of a COVID-19 vac...

Organ Transplants Fell by a Third Globally During Pandemic's First Wave
https://www.medscape.com/viewarticle/958383

Sep 9th, 2021 - NEW YORK (Reuters Health) - Organ transplants fell by a third globally during the first wave of the COVID-19 pandemic, but the impact varied across countries, providing an opportunity for cross-country learning to improve future preparedness, rese...

EPOCH Trial Seeks to Establish the Role of TheraSphere Y-90 in Second-Line Metastatic CRC
https://www.onclive.com/view/epoch-trial-seeks-to-establish-the-benefit-of-therasphere-y-90-in-second-line-metastatic-crc

Sep 2nd, 2021 - The safety and effectiveness of TheraSphere™ Yttrium-90 (Y-90) Glass Microspheres is under examination in patients with colorectal cancer with metastases in the liver who are scheduled to receive second-line chemotherapy as part of the ongoing EPO...

see more →

Patient Education  1 results see all →